EFTUD2

Chr 17

elongation factor Tu GTP binding domain containing 2

Also known as: MFDGA, MFDM, SNRNP116, Snrp116, Snu114, U5-116KD

This gene encodes a GTPase which is a component of the spliceosome complex which processes precursor mRNAs to produce mature mRNAs. Mutations in this gene are associated with mandibulofacial dysostosis with microcephaly. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

GeneReviewsResearchGenerating clinical summary…
LOFmechanismLOEUF 0.09
Clinical SummaryEFTUD2
🧬
Gene-Disease Validity (ClinGen)
mandibulofacial dysostosis-microcephaly syndrome · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
183 unique Pathogenic / Likely Pathogenic· 296 VUS of 961 total submissions
📖
GeneReview available — EFTUD2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.09LOEUF
pLI 1.000
Z-score 6.45
OE 0.02 (0.010.09)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
4.03Z-score
OE missense 0.52 (0.470.57)
293 obs / 561.5 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.02 (0.010.09)
00.351.4
Missense OE?0.52 (0.470.57)
00.61.4
Synonymous OE?0.95
01.21.6
LoF obs/exp: 1 / 50.4Missense obs/exp: 293 / 561.5Syn Z: 0.55
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveEFTUD2-related mandibulofacial dysostosis with microcephalyLOFAD

This gene — mechanism propensity

DN
0.4488th %ile
GOF
0.5661th %ile
LOF
0.64top 25%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOF1 literature citation · 81% of P/LP variants are LoF · LOEUF 0.09 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Literature Evidence

LOFTogether, these data support a model in which EFTUD2 haploinsufficiency leads to the mis-splicing of a distinct subset of pre-mRNAs with a widespread effect on gene expression, including altering the expression of ER stress response genes and genes involved in the development of the craniofacial reg1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 31304552

ClinVar Variant Classifications

961 submitted variants in ClinVar

Classification Summary

Pathogenic100
Likely Pathogenic83
VUS296
Likely Benign296
Benign98
Conflicting26
100
Pathogenic
83
Likely Pathogenic
296
VUS
296
Likely Benign
98
Benign
26
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
90
7
2
1
100
Likely Pathogenic
58
18
6
1
83
VUS
1
254
34
7
296
Likely Benign
1
13
147
135
296
Benign
0
3
86
9
98
Conflicting
26
Total150295275153899

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

14 pathogenic / likely-pathogenic (of 15) ClinVar copy-number / structural variants overlap EFTUD2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

EFTUD2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →